MedShare

Advanced Search

Investigating the mechanism by which the anti-HIV drug abacavir influences MHC class I peptide selection

Investigating the mechanism by which the anti-HIV drug abacavir influences MHC class I peptide selection

Research Project Report (2017-2018)

Author: Miss Hana Ellingham
Supervisor: Dr Andy Van Hateren, Professor Tim Elliott
Group: Immunology and Immunotherapy
Keywords: abacavir, hla*b57:01, abacavir hypersensitivity syndrome, tapasin, tapbpr

Toolbox